Table 3. Upregulated serum miRNAs evaluated by qRT–PCR in the peripheral blood of patients with gastric cancer when compared with healthy controls.
miRNAs | ΔCthealthy | ΔCtcancer | ΔΔCt | 2–ΔΔCt | Corrected Pa |
---|---|---|---|---|---|
miR-518f | −4.50±10.78 | −12.35±1.99 | −7.85 | 230.67 | 0.017 |
miR-130a | 10.96±3.48 | 6.62±3.42 | −4.34 | 20.22 | 0.017 |
miR-212 | 8.81±2.36 | 4.58±2.65 | −4.22 | 18.70 | 0.007 |
miR-220 | 7.85±2.51 | 3.85±2.81 | −4.00 | 15.98 | 0.017 |
miR-433 | 9.03±1.67 | 5.19±3.15 | −3.84 | 14.29 | 0.025 |
miR-518d | 8.77±3.76 | 5.43±3.24 | −3.35 | 10.18 | 0.037 |
miR-331 | 6.54±2.61 | 3.31±3.34 | −3.23 | 9.40 | 0.039 |
miR-19a | 8.39±4.07 | 5.18±3.55 | −3.21 | 9.23 | 0.042 |
miR-365 | 10.66±3.22 | 7.62±3.12 | −3.04 | 8.25 | 0.037 |
miR-374 | 8.48±3.24 | 5.55±2.94 | −2.93 | 7.62 | 0.037 |
miR-296 | 7.74±4.29 | 4.86±3.14 | −2.88 | 7.37 | 0.039 |
miR-323-3p | 9.21±1.60 | 6.59±2.94 | −2.63 | 6.18 | 0.046 |
miR-21 | 4.05±2.33 | 1.73±2.45 | −2.33 | 5.02 | 0.017 |
miR-146b | 6.95±2.34 | 4.64±2.21 | −2.31 | 4.97 | 0.037 |
miR-146a | 5.99±2.19 | 3.68±2.65 | −2.31 | 4.96 | 0.025 |
miR-106a | 4.30±2.77 | 2.10±2.51 | −2.19 | 4.57 | 0.025 |
miR-223 | −2.65±2.32 | −4.78±2.57 | −2.12 | 4.35 | 0.025 |
miR-19b | 2.45±2.23 | 0.36±2.63 | −2.09 | 4.26 | 0.025 |
miR-451 | 0.68±2.31 | −1.41±2.84 | −2.08 | 4.23 | 0.037 |
miR-30c | 4.95±3.3 | 2.90±2.65 | −2.05 | 4.14 | 0.037 |
Abbreviations: miRNA=microRNA; qRT–PCR=quantitative reverse transcriptase PCR.
Values are expressed as means±s.d.
ΔCt=Ct sample−Ct average expression of cel-miR-39 and miR-191-5p.
ΔΔCt=ΔCt cancer−ΔCt healthy.
Benjamini, Krieger, and Yekutieli correction for multiple testing.